Raymond Tu, MD, discusses the considerations for implementing a new lower dose mammography system, including patient safety, market share, and cost.
[[{"type":"media","view_mode":"media_crop","fid":"11562","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_9305716539806","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"205","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]When United Medical Center in Washington, D.C., upgraded their film-screen mammography system, they had several factors to consider, including how to best meet the needs of their underserved patient population while keeping costs in mind.
The push to lower radiation dose was also a major factor, said Raymond Tu, chairman of the Radiology Department at UMC and president of the American College of Radiology's Washington, D.C., chapter. In this podcast, Tu discusses why UMC opted for Philips’ MicroDose Mammography system, which the company launched in North America last fall.
Here, Tu details:
• The unique needs of his patient population, and how that factored into the selection of a new technology,
• The desire to select a solution that would help the group’s market share in the area, and
• The constraining factors keeping the industry from doing more to implement lower dose technologies.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.